Breaking News
Sort by:
Top Post
Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
Abbott (NYSE: ABT) today announced it’s developing a new biowearable that will continuously monitor glucose and […]
Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and GO Therapeutics, Inc. (Co-Founder […]
Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage Cancers
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or […]
Roche’s Polivy Combination Approved by European Commission for People With Previously Untreated Diffuse Large B-cell Lymphoma
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission (EC) has granted […]
RemedyBio Introduces Scientific Advisory Board
RemedyBio, a biotech company pioneering its proprietary ultra-high throughput single cell Nanoreactor™ platform for discovery […]
NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment
NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as […]
Healthcare is failing Gen Z - New innovation offers potential 97% saving to NHS
LovedBy, the health technology and consultancy business, today announces the launch of ‘Nudg with Dexcom’ […]
FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder
Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) […]
CHMP Recommends Approval of Lilly and Incyte's OLUMIANT® (baricitinib) as the First and Only Centrally-Authorized Treatment for Adults with Severe Alopecia Areata (AA)
Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the European Medicines Agency’s […]
BenevolentAI Achieves Third Milestone in Its AI-enabled Drug Discovery Collaboration With AstraZeneca
BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI-enabled drug discovery company, today announces that AstraZeneca […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more